Cargando…

Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction

Non-alcoholic fatty liver disease (NAFLD) is a common disease in Western nations and ranges in severity from steatosis to steatohepatitis (NASH). NAFLD is a genetic-environmental-metabolic stress-related disease of unclear pathogenesis. NAFLD is triggered by caloric overconsumption and physical inac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Liang, Nagata, Naoto, Ota, Tsuguhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929181/ https://www.ncbi.nlm.nih.gov/pubmed/31775341 http://dx.doi.org/10.3390/ijms20235920

Ejemplares similares

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Bioavailability of Glucoraphanin and Sulforaphane from High‐Glucoraphanin Broccoli
por: Sivapalan, Tharsini, et al.
Publicado: (2018)

Genetic regulation of glucoraphanin accumulation in Beneforté® broccoli
por: Traka, Maria H, et al.
Publicado: (2013)

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Xu, Liang, et al.
Publicado: (2015)

Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice
por: Yao, Wei, et al.
Publicado: (2016)

Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
por: Fuke, Nobuo, et al.
Publicado: (2019)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
por: Kitade, Hironori, et al.
Publicado: (2017)

Optimization of Engineered Production of the Glucoraphanin Precursor Dihomomethionine in Nicotiana benthamiana
por: Crocoll, Christoph, et al.
Publicado: (2016)

Causes of erectile dysfunction in non-alcoholic fatty liver disease
por: Tarik Kani, Haluk, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions
por: Yang, Min, et al.
Publicado: (2014)

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
por: Lee, Dong Ho
Publicado: (2017)

Increased Nitroxidative Stress Promotes Mitochondrial Dysfunction in Alcoholic and Nonalcoholic Fatty Liver Disease
por: Song, Byoung-Joon, et al.
Publicado: (2013)

Broccoli-Derived Glucoraphanin Activates AMPK/PGC1α/NRF2 Pathway and Ameliorates Dextran-Sulphate-Sodium-Induced Colitis in Mice
por: Tian, Qiyu, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
por: Antonucci, Laura, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity
por: Kwak, Min-Sun, et al.
Publicado: (2018)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
por: Eguchi, Yuichiro, et al.
Publicado: (2020)

Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
por: Ramanathan, Raghu, et al.
Publicado: (2022)

Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase
por: Fahey, Jed W., et al.
Publicado: (2015)

Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
por: Wang, Dan, et al.
Publicado: (2023)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model
por: Lu, Zhuo, et al.
Publicado: (2022)

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
por: Zheng, Youwei, et al.
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
por: Deng, Yuanjun, et al.
Publicado: (2019)

Garcinia cambogia Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation
por: Han, Joo-Hui, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
por: Matsuura, Akiko, et al.
Publicado: (2018)

Dietary Broccoli Alters Rat Cecal Microbiota to Improve Glucoraphanin Hydrolysis to Bioactive Isothiocyanates
por: Liu, Xiaoji, et al.
Publicado: (2017)

Beneficial Effect of H(2)S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin
por: Micheli, Laura, et al.
Publicado: (2022)

Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
por: Kjærgaard, Kristoffer, et al.
Publicado: (2021)

Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
por: Robea, Madalina Andreea, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o4ib1qt3kuumvrttnf8at460vi